Europe — EMA
Mutaflor (Escherichia Coli Strain Nissle 1917)
GNH USA supplies Mutaflor (Escherichia coli Nissle 1917), a probiotic for ulcerative colitis, inflammatory bowel disease and IBS.
Request sourcing
What is Escherichia Coli Strain Nissle 1917?
Escherichia coli Nissle 1917, the active ingredient in Mutaflor, is a probiotic presented as a capsule for oral use. It is employed to support gastrointestinal health and is indicated for maintenance therapy in ulcerative colitis and other inflammatory bowel conditions.
GNH USA supplies Mutaflor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Escherichia Coli Strain Nissle 1917 used for?
Mutaflor is a probiotic that acts on the gastrointestinal microbiota and is employed in several chronic intestinal disorders.
- Ulcerative colitis: helps maintain remission and reduces flare‑ups. - Inflammatory bowel disease: may lower disease activity and support mucosal healing. - Irritable bowel syndrome: can improve abdominal discomfort and bowel habit regularity.
What are the side effects of Escherichia Coli Strain Nissle 1917?
Adverse reactions are generally mild and related to gastrointestinal tolerance.
Common Side Effects: - Mild abdominal discomfort - Flatulence or bloating - Nausea - Diarrhea - Headache - Transient constipation
Serious or Rare Side Effects: - Bacteremia or sepsis, particularly in immunocompromised patients - Severe allergic reaction (anaphylaxis, rash, swelling) - Persistent fever - Unexplained weight loss - Severe abdominal pain
What precautions apply to Escherichia Coli Strain Nissle 1917?
Before initiating Mutaflor, consider patient‑specific factors and monitor for potential risks.
- Assess immune status: use with caution in immunocompromised individuals. - Review infection history: avoid in patients with recent systemic infections. - Evaluate hypersensitivity: discontinue if allergic reactions occur. - Monitor pediatric use: safety data are limited in children. - Store at ambient temperature: keep in the original pack, protect from moisture.
What does Escherichia Coli Strain Nissle 1917 interact with?
Mutaflor may interact with other agents that affect gut flora or immune function.
Major Interactions (Avoid): - Broad‑spectrum antibiotics: can eradicate the probiotic strain and diminish efficacy. - Systemic immunosuppressants: increase risk of opportunistic infection.
Moderate Interactions (Monitor Closely): - Proton‑pump inhibitors: may alter gastric pH and affect bacterial survival. - Antacids containing aluminum or magnesium: could impact colonisation. - Concurrent probiotic products: potential competition for intestinal niches.



